WO2019050546A2 - Méthodes de traitement et de prévention de l'insuffisance hépatique aiguë - Google Patents

Méthodes de traitement et de prévention de l'insuffisance hépatique aiguë Download PDF

Info

Publication number
WO2019050546A2
WO2019050546A2 PCT/US2017/050993 US2017050993W WO2019050546A2 WO 2019050546 A2 WO2019050546 A2 WO 2019050546A2 US 2017050993 W US2017050993 W US 2017050993W WO 2019050546 A2 WO2019050546 A2 WO 2019050546A2
Authority
WO
WIPO (PCT)
Prior art keywords
liver
subject
stem cell
cells
alf
Prior art date
Application number
PCT/US2017/050993
Other languages
English (en)
Inventor
Jennifer Hui-Chun Ho
Ryan Chang
Oscar Kuang-Sheng Lee
Niang-Cheng LIN
Chin-Su LUI
Original Assignee
Steminent Biotherapeutics Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steminent Biotherapeutics Inc. filed Critical Steminent Biotherapeutics Inc.
Priority to PCT/US2017/050993 priority Critical patent/WO2019050546A2/fr
Priority to TW107131238A priority patent/TW201919665A/zh
Publication of WO2019050546A2 publication Critical patent/WO2019050546A2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PCT/US2017/050993 2017-09-11 2017-09-11 Méthodes de traitement et de prévention de l'insuffisance hépatique aiguë WO2019050546A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/US2017/050993 WO2019050546A2 (fr) 2017-09-11 2017-09-11 Méthodes de traitement et de prévention de l'insuffisance hépatique aiguë
TW107131238A TW201919665A (zh) 2017-09-11 2018-09-06 治療及預防急性肝衰竭的方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2017/050993 WO2019050546A2 (fr) 2017-09-11 2017-09-11 Méthodes de traitement et de prévention de l'insuffisance hépatique aiguë

Publications (1)

Publication Number Publication Date
WO2019050546A2 true WO2019050546A2 (fr) 2019-03-14

Family

ID=65634130

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/050993 WO2019050546A2 (fr) 2017-09-11 2017-09-11 Méthodes de traitement et de prévention de l'insuffisance hépatique aiguë

Country Status (2)

Country Link
TW (1) TW201919665A (fr)
WO (1) WO2019050546A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2693677C1 (ru) * 2018-10-15 2019-07-03 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) Способ гемокоррекции при лечении печеночной недостаточности

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2693677C1 (ru) * 2018-10-15 2019-07-03 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) Способ гемокоррекции при лечении печеночной недостаточности

Also Published As

Publication number Publication date
TW201919665A (zh) 2019-06-01

Similar Documents

Publication Publication Date Title
Hu et al. Exosomal Mst1 transfer from cardiac microvascular endothelial cells to cardiomyocytes deteriorates diabetic cardiomyopathy
Strom et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure
Jorns et al. Hepatocyte transplantation for inherited metabolic diseases of the liver
KR101893717B1 (ko) 분리된 신장 세포 및 이의 용도
US20200405913A1 (en) Injectable cell and scaffold compositions
US20120276067A1 (en) Assay for the Prediction of Therapeutic Effectiveness of Mesenchymal Stromal Cells, and Methods of Using Same
Gao et al. Adipose-derived mesenchymal stem cells promote liver regeneration and suppress rejection in small-for-size liver allograft
López et al. Platelet increases survival in a model of 90% hepatectomy in rats
Citro et al. Directed self-assembly of a xenogeneic vascularized endocrine pancreas for type 1 diabetes
Benck et al. Donor dopamine does not affect liver graft survival: evidence of safety from a randomized controlled trial
Lin et al. Mesenchymal stem cells prolong survival and prevent lethal complications in a porcine model of fulminant liver failure
Han et al. Fat‐associated lymphoid clusters as expandable niches for ectopic liver development
Piao et al. Optimal intervention time of ADSCs for hepatic ischemia-reperfusion combined with partial resection injury in rats
WO2019050546A2 (fr) Méthodes de traitement et de prévention de l'insuffisance hépatique aiguë
Danilova et al. Recruitment of macrophages and bone marrow stem cells to regenerating liver promoted by sodium phthalhydrazide in mice
Buchko et al. A low-cost perfusate alternative for ex vivo lung perfusion
Uribe-Cruz et al. Encapsulated whole bone marrow cells improve survival in wistar rats after 90% partial hepatectomy
JP7452934B2 (ja) 慢性肝不全の急性憎悪の治療のための成人肝前駆細胞
TW202100171A (zh) 用於治療非酒精性脂肪肝疾病的成人肝臟前驅細胞
Aerts-Kaya et al. SUL-109 Protects Hematopoietic Stem Cells from Apoptosis Induced by Short-Term Hypothermic Preservation and Maintains Their Engraftment Potential
US20170218340A1 (en) Method of culturing cells
US20240024370A1 (en) Pharmaceutical composition including adipose-derived regenerative cells (adrcs) for use in prevention and treatment of liver fibrosis or liver cirrhosis
Moor et al. Comparative analysis of kidney transplantation modeled using precision-cut kidney slices and kidney transplantation in pigs
Cruz et al. Encapsulated whole bone marrow cells improve survival in wistar rats after 90% partial hepatectomy
Abdel-Aziz Novel therapeutic strategies for prevention of postresectional liver failure

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17924211

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17924211

Country of ref document: EP

Kind code of ref document: A2